Clinical trial
Investigating the Neural Correlates of Cognitive Function Associated With Cannabis Abstinence in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
NCT05445180 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Neural Correlates of Cognitive Function Associated With Cannabis Abstinence in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
- Lead sponsor
- Douglas Mental Health University Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 21, 2022
- Completion date
- May 31, 2027
- Enrollment
- 134 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cannabis dependence, cannabis use, cannabis use disorder, cognitive dysfunction, memory impairment, neuroimaging, psychotic disorders, schizophrenia; psychosis